Newswire (Published: Tuesday, May 30, 2017, Received: Thursday, May 25, 2017, 7:21:09 PM CDT)

Word Count: 431

Data on Prostate Cancer Detailed by Researchers at Hiroshima University Institute of Biomedical and Health Sciences (Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower ...)

By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting originating in Hiroshima, Japan, by NewsRx journalists, research stated, "Prostate cancer, one of the most common malignant tumors among men, is closely associated with obesity and, thus far, several studies have suggested the association between obesity and aggressive pathological characteristics in the United States. However, the effect of obesity on prostate cancer mortality is controversial, and it remains unclear whether obesity contributes to the aggressiveness of prostate cancer in Asian patients."

The news reporters obtained a quote from the research from the Hiroshima University Institute of Biomedical and Health Sciences, "The aim of the present study was to investigate the association between body mass index (BMI) and the clinicopathological characteristics of prostate cancer in 2,003 Japanese patients who underwent radical prostatectomy. There was a significant association between higher BMI and higher Gleason score (GS). The multivariate analysis also revealed that BMI was an independent indicator for GS greater than or equal to8 at surgery. Moreover, among patients with lower prostate-specific antigen levels, biochemical recurrence-free survival was significantly worse in those with higher BMI."

According to the news reporters, the research concluded: "These results suggest that BMI may be a classifier for predicting adverse pathological findings and biochemical recurrence after radical prostatectomy in Japanese patients."

For more information on this research see: Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels. Molecular and Clinical Oncology, 2017;6(5):748-752 (see also Oncology - Prostate Cancer).

Our news correspondents report that additional information may be obtained by contacting K. Goto, Dept. of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima 734-8551, Japan. Additional authors for this research include H. Nagamatsu, J. Teishima, Y. Kohada, S. Fujii, Y. Kurimura, K. Mita, M. Shigeta, S. Maruyama, Y. Inoue, M. Nakahara and A. Matsubara.

Keywords for this news article include: Asia, Japan, Obesity, Surgery, Oncology, Hiroshima, Bariatrics, Kallikreins, Biochemicals, Biochemistry, Men's Health, Overnutrition, Prostatectomy, Endopeptidases, Prostate Cancer, Serine Proteases, Diet and Nutrition, Peptide Hydrolases, Nutrition Disorders, Prostatic Neoplasms, Enzymes and Coenzymes.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Places

Eastern Asia
North America
Japan
United States
Americas
Asia
Hiroshima

Subjects

Science and Technology
      Scientific Research
      Sciences
            Natural Sciences
                  Biology
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Obesity
            Urological Diseases
      Medical Specialties and Practices
            Urology